Pulmatrix, Inc.

Industry

  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
      • Pulmonary
  • Biotechnology

Other Names/Subsidiaries

  • Pulmatrix Operating Company
  • Ruthigen
See more in Biomedtracker

Latest on Pulmatrix, Inc.

Scrip

Deal Watch: Sarepta Targets RNAi In Broad Collaboration With Arrowhead

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sarepta Obtains Rights To Seven Arrowh

Scrip

Deal Watch: Vanda Gets Competing Offer From Cycle After Unsolicited Future Pak Bid

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cycle Offers $466m For Vanda, Which Tur

Generics Bulletin

Cipla Points To Large GLP-1 India Opportunity Amid Speculation On Lilly Deal

 
• By Anju Ghangurde

Cipla Limited had to tackle some pre-results drama, even as the company reported a strong showing for the third quarter of fiscal 2024, while management commentary on the glucagon‐like peptide 1 (GLP

Scrip

Cipla Points To Large GLP-1 India Opportunity Amid Speculation On Lilly Deal

 
• By Anju Ghangurde

Cipla Limited had to tackle some pre-results drama, even as the company reported a strong showing for the third quarter of fiscal 2024, while management commentary on the glucagon‐like peptide 1 (GLP